← Eichor
Condition: Hypertrophic Cardiomyopathy Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hypertrophic Cardiomyopathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Valsalva SBP Drop and LVOT Obstruction
Phase N/A · 1 location(s) · Shanghai Zhongshan Hospital · NCT07483125Taiwan Registry of Hypertrophic Cardiomyopathy (THIC) Research Synopsis
Phase N/A · 1 location(s) · Far Eastern Memorial Hospital · NCT06381778A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy
Phase 3 · 1 location(s) · Shandong Suncadia Medicine Co., Ltd. · NCT07021976Evaluation of HEArt invoLvement in Patients With FABRY Disease
Phase N/A · 1 location(s) · Wuerzburg University Hospital · NCT03362164A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopa
Phase N/A · 15 location(s) · Bristol-Myers Squibb · NCT07361289the Role of cArdiac Inflammation, endoThelial Dysfunction, and FIbrosis in fabrY Disease
Phase N/A · 1 location(s) · Caroline Michaela Kistorp · NCT06776419The Application of T1 Mapping in Real-World
Phase N/A · 1 location(s) · Chinese Academy of Medical Sciences, Fuwai Hospital · NCT07354646Large Language Models To Improve the Quality of Care of Cardiology Patients
NA · 1 location(s) · Stanford University · NCT06935253DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studie
Phase N/A · 1 location(s) · University Hospital Heidelberg · NCT04265040Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition
Phase N/A · 1 location(s) · University of Edinburgh · NCT06409585Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168ENavogliflozin DElivering Alleviation of Ventricular Diastolic Dysfunction in nonObstRuctive Hypertrophic CardioMyopathy
Phase 4 · 1 location(s) · Yonsei University · NCT06580717Mavacamten Post-marketing Surveillance in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan
Phase N/A · 1 location(s) · Bristol-Myers Squibb · NCT07383025The Heart Hive - Cardiomyopathy Study
Phase N/A · 1 location(s) · Imperial College London · NCT04612296LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atri
Phase 3 · 17 location(s) · Rennes University Hospital · NCT07202897Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation
Phase N/A · 3 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06813443Myocardial Perfusion Changes Following Optimal Medical Treatment in Symptomatic Hypertrophic Cardiomyopathy
Phase N/A · 1 location(s) · Medical University of Vienna · NCT07150299Institutional Registry of Rare Diseases
Phase N/A · 1 location(s) · Hospital Italiano de Buenos Aires · NCT06573723VIZ ACCESS HCM - Multi-Site Registry
Phase N/A · 3 location(s) · Viz.ai, Inc. · NCT07103057Study of the Progression of Chronic Cardiovascular Conditions
Phase N/A · 1 location(s) · Prolaio · NCT07420907Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients wit
Phase N/A · 1 location(s) · Scientific Institute San Raffaele · NCT06607471Mavacamten Enables Exercise in Hypertrophic Obstructive Cardiomyopathy
NA · 1 location(s) · Technical University of Munich · NCT07077005US Benchmarking Clinical Study
Phase N/A · 3 location(s) · eMyosound SAS · NCT07215715Austrian Hypertrophic Cardiomyopathy Registry
Phase N/A · 15 location(s) · Medical University of Graz · NCT06368518Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM
Phase N/A · 1 location(s) · Michael Ayers · NCT06023186A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
Phase 2 · 6 location(s) · Rocket Pharmaceuticals Inc. · NCT06092034Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
Phase 1 · 1 location(s) · Weill Medical College of Cornell University · NCT05302271Pediatric Cardiomyopathy Mutation Analysis
Phase N/A · 1 location(s) · Indiana University · NCT02432092A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy
Phase 2 · 1 location(s) · Shandong Suncadia Medicine Co., Ltd. · NCT06816251Etiological DiagnOsis of caRdiac Diseases Based on echoCardiograpHIc Images and Clinical Data.
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT05942729
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.